Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

17
Number of overlapping holdings
32.7%
% of PINK's 53 holdings also in GDOC
37.8%
% of GDOC's 48 holdings also in PINK
Overlap by Weight
Sector Drift (PINK minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PINK |
Weight in GDOC |
Overlap | |
---|---|---|---|---|
BOSTON SCIENTIFIC CORP | 5.8% | 5.5% | 5.5% | |
ELI LILLY & CO | 5.1% | 8.4% | 5.1% | |
INTUITIVE SURGICAL INC | 3.9% | 4.9% | 3.9% | |
DEXCOM INC | 2.9% | 2.9% | 2.9% | |
ZIMMER HOLDINGS INC | 3.3% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
PINK Overweight Relative to GDOC
SANOFI-AVENTIS-ADR | 7.8% | |
REGENERON PHARMACEUTICALS | 6.3% | |
CIGNA CORPORATION | 4.9% | |
JOHNSON & JOHNSON | 4.7% | |
VERTEX PHARMACEUTICALS INC | 4.6% | |
AMGEN INC | 4.3% | |
MEDTRONIC PLC | 4.3% | |
UNITEDHEALTH GROUP INC | 4.1% | |
ABBVIE INC | 3.6% | |
MERCK & CO. INC. | 3.6% |
PINK Underweight Relative to GDOC
ASTRAZENECA PLC | -5.2% | |
ELI LILLY & CO | -3.3% | |
BIOGEN IDEC INC | -3.3% | |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% | |
SEATTLE GENETICS INC | -3.1% | |
CSL LIMITED | -2.9% | |
BIOMARIN PHARMACEUTICAL INC | -2.8% | |
BRISTOL-MYERS SQUIBB CO | -2.8% | |
NEUROCRINE BIOSCIENCES INC | -2.8% | |
WEST PHARMACEUTICAL SERVICES | -2.5% |